AKT1 and neoplasm: Apart from the complex TCR signalling in the tumour microenvironment, we wish to emphasize activation of the PI3K/AKT pathway which is mediated through a range of kinases in response to insulin receptor and insulin receptor substrate signalling (Figure 6A).